This shows you the differences between two versions of the page.
Both sides previous revisionPrevious revisionNext revision | Previous revisionNext revisionBoth sides next revision | ||
home:mp [03.13.2019] – [Data] sallieq | home:mp [05.10.2019] – [Data] sallieq | ||
---|---|---|---|
Line 250: | Line 250: | ||
Olmesartan will need to be [[home: | Olmesartan will need to be [[home: | ||
+ | |||
+ | {{tag>MP summary}} | ||
===== Data ===== | ===== Data ===== | ||
[[home: | [[home: | ||
- | {{tag>MP summary}} | + | [[home: |
+ | |||
+ | ==== Success rates noted for 5 diagnoses ==== | ||
+ | |||
+ | | ||
+ | |||
+ | SUCCESS RATES: Over all success rate 66.32% Over all unsuccessful 13.77% Over all unsure 19.91% | ||
+ | |||
+ | Sarcoidosis success 75.8% | ||
+ | |||
+ | Chronic Fatigue Syndrome success 60.1% | ||
+ | |||
+ | Lyme disease success 66.9% | ||
+ | |||
+ | Rheumatoid arthritis success 69.2% | ||
+ | |||
+ | Fibromyalgia success 64.2% | ||
+ | |||
+ | All Other Th1 disease success 59.8% | ||
===== Notes and comments ===== | ===== Notes and comments ===== | ||